SCHEMBL2017565

SCHEMBL2017565

CN(C(=O)c1ccc2ncsc2c1)C(CCNC(=O)c1cccn1C)Cc1ccccc1

nearest known ligand 0.66

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 2/20 0.66
HCRTR2 O43614 2/20 0.66
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
IRAK4 Q9NWZ3 5/20 0.42
JAK3 P52333 3/20 0.42
TAS1R3 Q7RTX0 1/20 0.40
TAS1R1 Q7RTX1 1/20 0.40
MAPK8 P45983 1/20 0.40
CYP3A4 P08684 1/20 0.39
PDE10A Q9Y233 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
HDAC3 O15379 1/20 0.38
HDAC1 Q13547 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2011513 0.94 HCRTR1 (0.66) HCRTR1HCRTR2NPC1RAB9AIRAK4
SCHEMBL2013242 0.87 HCRTR1 (0.70) HCRTR1HCRTR2NPC1RAB9AALDH1A1
SCHEMBL2015950 0.87 HCRTR1 (0.70) HCRTR1HCRTR2NPC1RAB9AALDH1A1
SCHEMBL2013098 0.86 HCRTR1 (0.66) HCRTR1HCRTR2NPC1RAB9ASMN1; SMN2
SCHEMBL2013785 0.85 HCRTR1 (0.67) HCRTR1HCRTR2NPC1RAB9ASMN1; SMN2
SCHEMBL2015002 0.84 HCRTR1 (0.69) HCRTR1HCRTR2NPC1RAB9AHDAC3
SCHEMBL2014534 0.84 HCRTR1 (0.66) HCRTR1HCRTR2NPC1RAB9ATAS1R3
SCHEMBL13139060 0.83 HCRTR1 (0.77) HCRTR1HCRTR2NPC1RAB9AKMT2A
SCHEMBL2012143 0.83 HCRTR1 (0.63) HCRTR1HCRTR2NPC1RAB9ASMN1; SMN2
SCHEMBL2017387 0.82 HCRTR1 (0.71) HCRTR1HCRTR2NPC1RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO claimed
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO disclosed